Development and characterization of highly selective target-sensitive liposomes for the delivery of streptokinase: in vitro/in vivo studies

Vaidya, Bhuvaneshwar ; Nayak, Manasa K. ; Dash, Debabrata ; Agrawal, Govind P. ; Vyas, Suresh P. (2016) Development and characterization of highly selective target-sensitive liposomes for the delivery of streptokinase: in vitro/in vivo studies Drug Delivery, 23 (3). pp. 791-797. ISSN 1071-7544

Full text not available from this repository.

Official URL: http://www.tandfonline.com/doi/abs/10.3109/1071754...

Related URL: http://dx.doi.org/10.3109/10717544.2014.916770

Abstract

Streptokinase is one of the most commonly used thrombolytic agents for the treatment of thromboembolism. Short half-life of the streptokinase requires administration of higher dose which results in various side effects including systemic haemorrhage due to activation of systemic plasmin. To increase the selectivity of the streptokinase and hence to reduce side effects, various novel carriers have been developed. Among these carriers, liposomes have been emerged as versatile carrier. In the present study, highly selective target-sensitive liposomes were developed and evaluated by in vitro and in vivo studies. Prepared liposomes were found to release streptokinase in vitro following binding with activated platelets. Intravital microscopy studies in thrombosed murine model revealed higher accumulation of liposomes in the thrombus area. In vivo thrombolysis study was performed in the human clot inoculated rat model. Results of the study showed that target-sensitive liposomes dissolved 28.27 ± 1.56% thrombus as compared to 17.18 ± 1.23% of non-liposomal streptokinase. Further, it was also observed that target-sensitive liposomes reduced the clot dissolution time as compared to streptokinase solution. Studies concluded that developed liposomes might be pragmatic carriers for the treatment of thromboembolism.

Item Type:Article
Source:Copyright of this article belongs to Taylor & Francis.
Keywords:Streptokinase; Target-Sensitive Liposomes; Targeting; Thrombolytic Agents; Thrombus
ID Code:100954
Deposited On:04 Feb 2017 17:18
Last Modified:04 Feb 2017 17:18

Repository Staff Only: item control page